Log In
BCIQ
Print this Print this
 

Trokendi XR, topiramate (formerly SPN-538)

  Manage Alerts
Collapse Summary General Information
Company Supernus Pharmaceuticals Inc.
DescriptionExtended-release formulation of topiramate, a sodium channel blocker, GABA A receptor agonist, AMPA receptor antagonist and carbonic anhydrase inhibitor
Molecular Target Sodium channel ; GABA A receptor
Mechanism of ActionAMPA receptor antagonist; GABA A receptor agonist; Carbonic anhydrase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/15/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today